Evidence map›Paper›PMID 31127361›Full record

ArticleJournal of materials science. Materials in medicine2019

Efficacy of novel nano-hydroxyapatite/polyurethane composite scaffolds with silver phosphate particles in chronic osteomyelitis.

Dongli Zhang, Wen Liu, Xiang-Dong Wu, Xiaoqiang He, Xiao Lin, Han Wang, Jidong Li, Jiaxing Jiang, Wei Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Biomimetic Polyurethanes in Tissue Engineering.Biomimetics (Basel, Switzerland) · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dongli ZhangDepartment of orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Wen LiuDepartment of orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Xiang-Dong WuDepartment of orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Xiaoqiang HeDepartment of orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Xiao LinDepartment of orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Han WangDepartment of orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Jidong LiResearch Center for Nano-Biomaterials, Analytical & Testing Center, Sichuan University, Chengdu, 610064, China.
Jiaxing JiangResearch Center for Nano-Biomaterials, Analytical & Testing Center, Sichuan University, Chengdu, 610064, China.
Wei HuangDepartment of orthopedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. drhuangwei68@gmail.com.ORCID http://orcid.org/0000-0002-8894-0982

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, chronic osteomyelitis is still a challenging surgical problem. Unfortunately, the traditional clinical method using bone cement loaded antibiotics is restricted due to its non-biodegradability and limited release of antibiotics. Hydroxyapatite is a good adsorbent with good biocompatibility, an ideal bone repair material, and can avert the requirement for the secondary surgical procedure of removal. In this study, nano-hydroxyapatite combined with a polyurethane containing 3% silver (Ag/n-HA/PU) was synthesized, and investigated for its efficacy of treating chronic bone infection with bone defects. To clarify its silver ions release characteristics, the concentration of the Ag

Indexed as

Bone SubstitutesAdsorptionAnimalsAnti-Bacterial AgentsBiocompatible MaterialsBone RegenerationChronic DiseaseDisease Models, AnimalDurapatiteMaleNanoparticlesOsteomyelitisPhosphatesPolyurethanesRabbitsSilver CompoundsAnti-Bacterial AgentsBiocompatible MaterialsBone SubstitutesDurapatitePhosphatesPolyurethanesSilver Compoundssilver phosphateTolonium Chloride

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.